NodThera Charts Obesity Future with First Patients Dosed in Phase 2 RESOLVE-1 Trial of Oral NLRP3 Inflammasome Inhibitor ...

While current drugs have made significant achievements in the management of obesity, their mechanisms primarily suppress the desire to eat (calorie restriction) or they promote a feeling of ...

NodThera Charts Obesity Future with First Patients Dosed in Phase 2 RESOLVE-1 Trial of Oral NLRP3 Inflammasome Inhibitor NT-0796 Pioneering small-molecule program, NT-0796, targets chronic ...

NVO advances obesity pipeline with CagriSema and Amycretin while expanding through major deals amid rising competition.

Novo Nordisk NVO shares have gained 5.8% in a week. The uptrend in the stock price was driven by reports of an activist hedge ...

The Singson clan of Ilocos Norte leads the pack with close to 20 seats. The Marcos-Romualdez clans and the Duterte family all also remain obese. In the gubernatorial races, 71 of 82 provinces remain ...

The body mass index (BMI) is under fire—many healthcare professionals, researchers, and fitness experts are questioning its ...

It was created in partnership with Amgen and contains expert commentary from cardiologist Sara Collins, M.D. The film’s ...

A street dog's severe obesity didn't allow him to move—until a rescuer stepped in. Months later, he’s unrecognizable. His ...

In that light, the GLP-1 rebound effect is not an obstacle but an opportunity to chart a new, holistic course in obesity care ...

Obesity can have a distinct impact on the absorption, effectiveness and excretion of antibiotics, medications that have been in use for more than 80 years, but only now have consensus guidelines been ...